The lower limit of patient age exclusion relates to the legal age of adults capable of signing informed consent to participate in the trial in the United States
Meaningful immune rebalancing typically requires 3-6 months Tissue repair (TB-500, BPC-157): Varies by tissue type and damage extent, typically 4-12 weeks for meaningful structural improvement Set realistic expectations
TB-500 is commonly discussed as a synthetic peptide fragment related to thymosin beta-4 biology
During pregnancy, B12 helps with fetal development and may prevent or treat symptoms associated with diabetic neuropathy
It is under active review by the FDA's PCAC advisory panel, with a formal evaluation expected in July 2026
Research applications focus on slow-wave sleep promotion, stress hormone balance, and the neuroprotective properties of the peptide